Email address | peter....@ecambiomed.com |
Name | Peter Jensen |
Country | United Kingdom and Norway and Guernsey |
5304001135 | |
Expertise/Background | President & CEO of eCAM Biomed Global Impact Fund for Impact Investment Fund Management for private investment in high impact outcomes. One primary goal: Deliver 10 billion vaccines in next 10 years. |
Hypothesis | Disintermediation of impact investors in capital markets to connect capital to open science innovation and delivery can greatly increase the speed of impact on infectious disease outbreaks and pandemic preparedness. |
Useful links | https://ecambiomed.com/ |
Comments | We believe open pharma, open science, open innovation, open collaboration of the global public health commons is the future of the 21st century, happening now at exponential rate, because of COVID-19 trigger. |